The research team projects that the PET Radiopharmaceuticals market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Cardinal Health Inc. (U.S.)
Nordion, Inc. (Canada)
Lantheus Medical Imaging, Inc. (U.S.)
Mallinckrodt plc (Ireland)
Eczacibasi-Monrol Nuclear Products (Turkey)
GE Healthcare (U.K.)
IBA Molecular Imaging (Belgium)
Bracco Imaging S.p.A (Italy)
Bayer AG (Germany)
Advanced Accelerator Applications S.A. (France)
By Type
F-18
Ru-82
Others
By Application
Oncology
Cardiology
Neurology
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of PET Radiopharmaceuticals 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the PET Radiopharmaceuticals Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the PET Radiopharmaceuticals Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the PET Radiopharmaceuticals market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by PET Radiopharmaceuticals Revenue
1.5 Market Analysis by Type
1.5.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 F-18
1.5.3 Ru-82
1.5.4 Others
1.6 Market by Application
1.6.1 Global PET Radiopharmaceuticals Market Share by Application: 2021-2026
1.6.2 Oncology
1.6.3 Cardiology
1.6.4 Neurology
1.6.5 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global PET Radiopharmaceuticals Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global PET Radiopharmaceuticals Market Players Profiles
3.1 Cardinal Health Inc. (U.S.)
3.1.1 Cardinal Health Inc. (U.S.) Company Profile
3.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
3.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Nordion, Inc. (Canada)
3.2.1 Nordion, Inc. (Canada) Company Profile
3.2.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
3.2.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Lantheus Medical Imaging, Inc. (U.S.)
3.3.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profile
3.3.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
3.3.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Mallinckrodt plc (Ireland)
3.4.1 Mallinckrodt plc (Ireland) Company Profile
3.4.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
3.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Eczacibasi-Monrol Nuclear Products (Turkey)
3.5.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profile
3.5.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
3.5.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 GE Healthcare (U.K.)
3.6.1 GE Healthcare (U.K.) Company Profile
3.6.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
3.6.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 IBA Molecular Imaging (Belgium)
3.7.1 IBA Molecular Imaging (Belgium) Company Profile
3.7.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
3.7.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Bracco Imaging S.p.A (Italy)
3.8.1 Bracco Imaging S.p.A (Italy) Company Profile
3.8.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
3.8.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Bayer AG (Germany)
3.9.1 Bayer AG (Germany) Company Profile
3.9.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
3.9.3 Bayer AG (Germany) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Advanced Accelerator Applications S.A. (France)
3.10.1 Advanced Accelerator Applications S.A. (France) Company Profile
3.10.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
3.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global PET Radiopharmaceuticals Market Competition by Market Players
4.1 Global PET Radiopharmaceuticals Production Capacity Market Share by Market Players (2015-2020)
4.2 Global PET Radiopharmaceuticals Revenue Market Share by Market Players (2015-2020)
4.3 Global PET Radiopharmaceuticals Average Price by Market Players (2015-2020)
5 Global PET Radiopharmaceuticals Production by Regions (2015-2020)
5.1 North America
5.1.1 North America PET Radiopharmaceuticals Market Size (2015-2020)
5.1.2 PET Radiopharmaceuticals Key Players in North America (2015-2020)
5.1.3 North America PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.1.4 North America PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia PET Radiopharmaceuticals Market Size (2015-2020)
5.2.2 PET Radiopharmaceuticals Key Players in East Asia (2015-2020)
5.2.3 East Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.2.4 East Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe PET Radiopharmaceuticals Market Size (2015-2020)
5.3.2 PET Radiopharmaceuticals Key Players in Europe (2015-2020)
5.3.3 Europe PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.3.4 Europe PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia PET Radiopharmaceuticals Market Size (2015-2020)
5.4.2 PET Radiopharmaceuticals Key Players in South Asia (2015-2020)
5.4.3 South Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.4.4 South Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia PET Radiopharmaceuticals Market Size (2015-2020)
5.5.2 PET Radiopharmaceuticals Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.5.4 Southeast Asia PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East PET Radiopharmaceuticals Market Size (2015-2020)
5.6.2 PET Radiopharmaceuticals Key Players in Middle East (2015-2020)
5.6.3 Middle East PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.6.4 Middle East PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa PET Radiopharmaceuticals Market Size (2015-2020)
5.7.2 PET Radiopharmaceuticals Key Players in Africa (2015-2020)
5.7.3 Africa PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.7.4 Africa PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania PET Radiopharmaceuticals Market Size (2015-2020)
5.8.2 PET Radiopharmaceuticals Key Players in Oceania (2015-2020)
5.8.3 Oceania PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.8.4 Oceania PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America PET Radiopharmaceuticals Market Size (2015-2020)
5.9.2 PET Radiopharmaceuticals Key Players in South America (2015-2020)
5.9.3 South America PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.9.4 South America PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World PET Radiopharmaceuticals Market Size (2015-2020)
5.10.2 PET Radiopharmaceuticals Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World PET Radiopharmaceuticals Market Size by Type (2015-2020)
5.10.4 Rest of the World PET Radiopharmaceuticals Market Size by Application (2015-2020)
6 Global PET Radiopharmaceuticals Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America PET Radiopharmaceuticals Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia PET Radiopharmaceuticals Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe PET Radiopharmaceuticals Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia PET Radiopharmaceuticals Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia PET Radiopharmaceuticals Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East PET Radiopharmaceuticals Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa PET Radiopharmaceuticals Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania PET Radiopharmaceuticals Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America PET Radiopharmaceuticals Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World PET Radiopharmaceuticals Consumption by Countries
7 Global PET Radiopharmaceuticals Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of PET Radiopharmaceuticals (2021-2026)
7.2 Global Forecasted Revenue of PET Radiopharmaceuticals (2021-2026)
7.3 Global Forecasted Price of PET Radiopharmaceuticals (2021-2026)
7.4 Global Forecasted Production of PET Radiopharmaceuticals by Region (2021-2026)
7.4.1 North America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.2 East Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.3 Europe PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.4 South Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.6 Middle East PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.7 Africa PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.8 Oceania PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.9 South America PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World PET Radiopharmaceuticals Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of PET Radiopharmaceuticals by Application (2021-2026)
8 Global PET Radiopharmaceuticals Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of PET Radiopharmaceuticals by Country
8.2 East Asia Market Forecasted Consumption of PET Radiopharmaceuticals by Country
8.3 Europe Market Forecasted Consumption of PET Radiopharmaceuticals by Countriy
8.4 South Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
8.5 Southeast Asia Forecasted Consumption of PET Radiopharmaceuticals by Country
8.6 Middle East Forecasted Consumption of PET Radiopharmaceuticals by Country
8.7 Africa Forecasted Consumption of PET Radiopharmaceuticals by Country
8.8 Oceania Forecasted Consumption of PET Radiopharmaceuticals by Country
8.9 South America Forecasted Consumption of PET Radiopharmaceuticals by Country
8.10 Rest of the world Forecasted Consumption of PET Radiopharmaceuticals by Country
9 Global PET Radiopharmaceuticals Sales by Type (2015-2026)
9.1 Global PET Radiopharmaceuticals Historic Market Size by Type (2015-2020)
9.2 Global PET Radiopharmaceuticals Forecasted Market Size by Type (2021-2026)
10 Global PET Radiopharmaceuticals Consumption by Application (2015-2026)
10.1 Global PET Radiopharmaceuticals Historic Market Size by Application (2015-2020)
10.2 Global PET Radiopharmaceuticals Forecasted Market Size by Application (2021-2026)
11 Global PET Radiopharmaceuticals Manufacturing Cost Analysis
11.1 PET Radiopharmaceuticals Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
12 Global PET Radiopharmaceuticals Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 PET Radiopharmaceuticals Distributors List
12.3 PET Radiopharmaceuticals Customers
12.4 PET Radiopharmaceuticals Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
The global Radiopharmaceuticals for Therapeutic market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market...
The global Therapeutic Radiopharmaceuticals market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...
The global Diagnostic Radiopharmaceuticals & Contrast Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will...
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases. Radiopharmaceuticals may be given to the patient in sever...
Overview of the Global Therapeutic Radiopharmaceuticals Market:The report discusses everything a marketer requires before investing in the global Therapeutic Radiopharmaceuticals Market during the forecast period 2023-2030. It provides detailed insight into current trends,...
Overview of the Global Radiopharmaceuticals in Nuclear Medical Market:The report discusses everything a marketer requires before investing in the global Radiopharmaceuticals in Nuclear Medical Market during the forecast period 2022-2029. It provides detailed insight into c...
Overview of the Global Radiopharmaceuticals in Nuclear Medicine Market:The report discusses everything a marketer requires before investing in the global Radiopharmaceuticals in Nuclear Medicine Market during the forecast period 2022-2029. It provides detailed insight into...
Nuclear medicine is a medical specialty which uses radioactive tracers to diagnose and treat disease. Specially designed cameras allow doctors to track the circulation, uptake and excretion of these radioactive tracers. Garnering a CAGR of 10.4% from 2022 to 2028, the global nuclear medicine & radio...
Radiation therapy is the treatment of cancer and other diseases with radiation. Radiation in various forms is used to kill the cancer cells by preventing them from multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. G...
Overview of the Europe Radiopharmaceuticals Market:The report discusses everything a marketer requires before investing in the Europe Radiopharmaceuticals Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market s...